| Typicality: | 0.288 |
| Saliency: | 0.447 |
| for both the mother | 6 | transitive-object |
| clinically | 2 | manner |
| in previous clinical trials | 2 | location |
| therapy → be proven to be → safe | 20 |
| therapy → be shown to be → safe | 13 |
| therapy → be proven → safe | 5 |
| negative | neutral | positive |
| 0.070 | 0.425 | 0.505 |
| Raw frequency | 38 |
| Normalized frequency | 0.447 |
| Modifier score | 0.300 |
| Perplexity | 38.584 |